NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Delphinus Medical Technologies

Delphinus Medical Technologies

Private
Novi, MichiganHealthcare & Life Scienceshttps://www.delphinusmt.com/

Last Round

Convertible Debt

Apr 3, 2025

Total Funding Raised

$153.66M

Company Overview

Delphinus Medical Technologies is a medical device company that develops and commercializes the SoftVue 3D whole-breast ultrasound tomography system for breast cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

whole-breast ultrasoundbreast cancer screeningdense breast tissueultrasound tomographymedical imaging hardwareadjunct screening3D ultrasoundradiation-free imagingbreast imagingautomated breast ultrasoundABUSdiagnostic imagingradiology equipmentcancer detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delphinus Medical Technologies Comps

Public and private peers based on sector, stage, and business model.

Delphinus Medical Technologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Delphinus Medical Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtApr 3, 2025
DebtAug 22, 2023
DebtJun 22, 2023
Series DSep 29, 2022
Series CSep 10, 2015
Series B
Sep 3, 2013

Delphinus Medical Technologies Investors

Notable investors and investment history

Delphinus Medical Technologies investors
InvestorRounds
North Coast Technology InvestorsSeries A, Series D, Series B, Series C
Arboretum VenturesSeries D, Series C, Series B, Series A
Waycross VenturesSeries D, Series C
BeringeaSeries A, Series D, Series C, Series B
Venture Investors LLCSeries D, Series C
Trinity CapitalDebt
Hopen Life Science VenturesSeries D, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2023

    $12M round led by Trinity Capital.

Delphinus Medical Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Delphinus Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Delphinus Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersNovi, Michigan
Employee Range21
Year Founded2010
Last FundingApr 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.